首页> 外文期刊>Saudi Journal of Gastroenterology >The efficacy of temporary placement of nasobiliary drainage following endoscopic metal stenting to prevent post-ERCP cholangitis in patients with cholangiocarcinoma
【24h】

The efficacy of temporary placement of nasobiliary drainage following endoscopic metal stenting to prevent post-ERCP cholangitis in patients with cholangiocarcinoma

机译:内镜下金属支架置入鼻胆管引流预防胆管癌患者发生ERCP后胆管炎的疗效

获取原文
           

摘要

Background/Aims: Although endoscopic metal biliary endoprosthesis (EMBE) is widely accepted as the most suitable drainage method for patients with unresectable malignant obstruction, uncontrolled post-procedural cholangitis is still a problem. We aimed to validate a new treatment modality to prevent post-ERCP cholangitis in patients with unresectable cholangiocarcinoma. Patients and Methods: A total of 378 patients who were diagnosed with unresectable malignant biliary obstruction and underwent EMBE or temporary endoscopic nasobiliary drainage (ENBD) following EMBE placement, from January 2010 to July 2016, were enrolled in this retrospective study. Incidence of cholangitis, related infectious indicators, success rate of biliary drainage, and occurrence of complications were evaluated. Results: The risk of overall cholangitis and related infectious indicators was significantly lower in EMBE plus ENBD group than that in EMBE group. The occurrence of cholangitis was 2.4% versus 11.9% (P = 0.004). On further analysis of subgroups, although no difference was detected in nonhilar cholangiocarcinoma subgroup, the incidence of cholangitis and related infectious indicators in hilar cholangiocarcinoma subgroup with EMBE modality were distinctly higher than that with EMBE plus ENBD modality (type I + II was 18.5% vs 0%, P 0.05; type III + IV was 19.8% vs 3.8%, P 0.05). No significant difference was found in successful biliary drainage rate and procedure-related complications when all subgroups were compared. Conclusions: The temporary placement of ENBD following EMBE is a simple and effective treatment modality to prevent post-ERCP cholangitis, especially in patients with hilar cholangiocarcinoma.
机译:背景/目的:尽管对于无法切除的恶性梗阻患者,内镜下金属胆管假体(EMBE)被广泛接受为最合适的引流方法,但仍无法控制手术后胆管炎。我们旨在验证一种新的治疗方法,以预防不可切除的胆管癌患者发生ERCP后胆管炎。患者与方法:2010年1月至2016年7月,共378名被诊断为不可切除的恶性胆道梗阻并在EMBE放置后接受EMBE或临时内镜鼻胆管引流术(ENBD)的患者参加了这项回顾性研究。评估胆管炎的发生率,相关的感染指标,胆管引流成功率和并发症的发生率。结果:EMBE + ENBD组的总胆管炎和相关感染指标的风险显着低于EMBE组。胆管炎的发生率为2.4%,而同期为11.9%(P = 0.004)。在亚组的进一步分析中,尽管在非肺门胆管癌亚组中未发现差异,但是具有EMBE模式的肝门胆管癌亚组中胆管炎的发生率和相关感染指标明显高于具有EMBE + ENBD模式的肝门胆管癌(I + II型为18.5%vs 0%,P <0.05; III + IV型分别为19.8%和3.8%,P <0.05)。比较所有亚组的成功胆汁引流率和手术相关并发症均无显着差异。结论:EMBE后临时放置ENBD是一种简单有效的治疗方法,可预防ERCP后胆管炎,特别是在肝门胆管癌患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号